Li Q - Search Results

1

Discovery and Modification of in Vivo Active Nrf2 Activators with 1,2,4-Oxadiazole Core: Hits Identification and Structure-Activity Relationship Study.

Xu LL, Zhu JF, Xu XL, Zhu J, Li L, Xi MY, Jiang ZY, Zhang MY, Liu F, Lu MC, Bao QC, Li Q, Zhang C, Wei JL, Zhang XJ, Zhang LS, You QD, Sun HP. Xu LL, et al. Among authors: li l, li q. J Med Chem. 2015 Jul 23;58(14):5419-36. doi: 10.1021/acs.jmedchem.5b00170. Epub 2015 Jul 7. J Med Chem. 2015. PMID: 26111355

2

Recent progress in the identification of selective butyrylcholinesterase inhibitors for Alzheimer's disease.

Li Q, Yang H, Chen Y, Sun H. Li Q, et al. Eur J Med Chem. 2017 May 26;132:294-309. doi: 10.1016/j.ejmech.2017.03.062. Epub 2017 Mar 27. Eur J Med Chem. 2017. PMID: 28371641 Review.

3

Therapeutic Agents in Alzheimer's Disease Through a Multi-targetdirected Ligands Strategy: Recent Progress Based on Tacrine Core.

Lin H, Li Q, Gu K, Zhu J, Jiang X, Chen Y, Sun H. Lin H, et al. Among authors: li q. Curr Top Med Chem. 2017;17(27):3000-3016. doi: 10.2174/1568026617666170717114944. Curr Top Med Chem. 2017. PMID: 28714419 Review.

4

Design, synthesis and evaluation of fused hybrids with acetylcholinesterase inhibiting and Nrf2 activating functions for Alzheimer's disease.

Wang Y, Xiong B, Lin H, Li Q, Yang H, Qiao Y, Li Q, Xu Z, Lyu W, Qu W, Liu W, Chen Y, Feng F, Sun H. Wang Y, et al. Among authors: li q. Eur J Med Chem. 2022 Dec 15;244:114806. doi: 10.1016/j.ejmech.2022.114806. Epub 2022 Oct 4. Eur J Med Chem. 2022. PMID: 36223681

5

Discovery of Novel Aldo-Keto Reductase 1C3 Inhibitors as Chemotherapeutic Potentiators for Cancer Drug Resistance.

He S, Liu Y, Chu X, Li Q, Lyu W, Liu Y, Xing S, Feng F, Liu W, Guo Q, Zhao L, Sun H. He S, et al. Among authors: li q. ACS Med Chem Lett. 2022 Jul 8;13(8):1286-1294. doi: 10.1021/acsmedchemlett.2c00175. eCollection 2022 Aug 11. ACS Med Chem Lett. 2022. PMID: 35978698 Free PMC article.

6

A highly effective and stable butyrylcholinesterase inhibitor with multi-faceted neuroprotection and cognition improvement.

Li Q, Xiong B, Wang Y, Lyu W, Xing S, Chen Y, Liao Q, He S, Feng F, Liu W, Chen Y, Sun H. Li Q, et al. Eur J Med Chem. 2022 Sep 5;239:114510. doi: 10.1016/j.ejmech.2022.114510. Epub 2022 Jun 7. Eur J Med Chem. 2022. PMID: 35728508

7

Medicinal Prospects of Targeting Tyrosinase: A Feature Review.

Wang Y, Xiong B, Xing S, Chen Y, Liao Q, Mo J, Chen Y, Li Q, Sun H. Wang Y, et al. Among authors: li q. Curr Med Chem. 2023;30(23):2638-2671. doi: 10.2174/0929867329666220915123714. Curr Med Chem. 2023. PMID: 36111760 Review.

8

Gamma secretase inhibitors: a patent review (2013 - 2015).

Gu K, Li Q, Lin H, Zhu J, Mo J, He S, Lu X, Jiang X, Sun H. Gu K, et al. Among authors: li q. Expert Opin Ther Pat. 2017 Jul;27(7):851-866. doi: 10.1080/13543776.2017.1313231. Epub 2017 Apr 10. Expert Opin Ther Pat. 2017. PMID: 28350212 Review.

9

Synthesis and bio-evaluation of a novel selective butyrylcholinesterase inhibitor discovered through structure-based virtual screening.

Xing S, Chen Y, Xiong B, Lu W, Li Q, Wang Y, Jiao M, Feng F, Chen Y, Liu W, Sun H. Xing S, et al. Among authors: li q. Int J Biol Macromol. 2021 Jan 1;166:1352-1364. doi: 10.1016/j.ijbiomac.2020.11.015. Epub 2020 Nov 6. Int J Biol Macromol. 2021. PMID: 33161083

10

Discovery of Resorcinol-Based Polycyclic Structures as Tyrosinase Inhibitors for Treatment of Parkinson's Disease.

Li Q, Mo J, Xiong B, Liao Q, Chen Y, Wang Y, Xing S, He S, Lyu W, Zhang N, Sun H. Li Q, et al. ACS Chem Neurosci. 2022 Jan 5;13(1):81-96. doi: 10.1021/acschemneuro.1c00560. Epub 2021 Dec 9. ACS Chem Neurosci. 2022. PMID: 34882402

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65,912 results

Search Page

Filters